Today's Daily Dose brings you news about wide acceptance of AVITA Medical's RECELL System for burns in the U.S.; FDA's "MRI safe" notice to Senseonics' Eversense; SCYNEXIS' positive phase III results in patients with refractory or intolerant fungal disease; and Surmodics' better-than-expected fiscal 2019 first quarter results and revised outlook.
from RTT - Biotech http://bit.ly/2Si3MrE
via IFTTT
No comments:
Post a Comment